Non-Compliant Balloons Improve Bifurcation Outcomes

Courtesy of Dr. Carlos Fava.

non compliant balloonsThe provisional approach is the standard strategy to treat bifurcations, but it might cause dissection of the ostium, a serious complication of the side branch. The use of non-compliant balloons (NCB) ensures uniform, constant, and controlled expansion along balloon length, reducing the risk of dissection.

The COBIS II registry enrolled 2,897 patients with bifurcation lesions (≥2.5 mm main vessel and ≥2.3 mm side branch diameters).

26% (752 patients) were treated with NCB. After propensity score matching, there were 710 patients in each group.

Procedural success was higher in patients receiving NCB:

 

With NCB: 79%

Without NCB: 73.9%

[p=0.01]

 

Angiographic success of side branch was:

 

With NCB: 79.7 %

Without NCB: 75.4%

[p=0.03].

 

The use of NCB positively correlated with lower SB dissection (0.1% vs. 1.1%; p=0.04)

Follow up was at 36 months in 96.3% of the population. Combined events rate resulted lower in the NCB group (HR 0.64, CI 95% 0.46-0.91; p=0.01), same as cardiac death (HR 0.14, CI 95% 0.03-0. 64; p=0.01) and stent thrombosis (probable, definite and possible) and there was a tendency towards a lower target vessel revascularization rate.

 

Conclusion

The use of non-compliant balloons was associated to a lower rate of events after PCI at long term in patients with bifurcation lesions in coronary arteries.

 

Editorial Comment

Bifurcations are gaining in complexity, as more experienced operators and new stents advance over more challenging lesions.

The new advancement in balloons to improve stent implantation and the new suggested techniques such as proximal optimization (POT) will ensure better results in more and more complex lesions.

 

Courtesy of Dr. Carlos Fava. Favaloro Foundation, Buenos Aires, Argentina.

 

 

Original Title: Impact of non-compliant balloons on long-term clinical outcomes in coronary bifurcation lesion: results from the COBIS (COronary BIfurcation Stent) II registry

Reference: Taek Kyu Park, et al. EuroIntervention2016;12:456-464

 

We value your opinion. You are more than welcome to leave your comments, thoughts, questions or suggestions here below.

More articles by this author

High Ischaemic Risk Criteria in Chronic Coronary Syndrome: Prevalence and Prognosis

Despite advances in the management of chronic coronary syndrome (CCS), including the widespread use of drug-eluting stents (DES) and the optimization of medical therapy,...

ACC 2026 | DKCRUSH VIII: IVUS or angiography to guide PCI in complex coronary bifurcations

Intracoronary imaging guidance has become an established recommended strategy in complex coronary lesions. In the specific setting of complex bifurcations, uncertainty remained regarding the...

ACC 2026 | OPTIMAL: IVUS Guidance in PCI of the Unprotected Left Main Coronary Artery

Percutaneous coronary intervention (PCI) is considered an equivalent alternative to coronary artery bypass surgery in patients with left main coronary artery (LMCA) stenosis and...

ACC 2026 | IVUS-CHIP Trial: Intravascular ultrasound–guided versus angiography-guided complex PCI

Optimization of percutaneous coronary intervention (PCI) in complex lesions remains a relevant clinical challenge. In this context, the IVUS-CHIP trial was designed to evaluate...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Mechanical thrombectomy versus anticoagulation in intermediate-risk pulmonary embolism: systematic review and meta-analysis

Intermediate-risk pulmonary embolism (PE) has anticoagulation as the standard treatment, while reperfusion strategies remain a matter of debate. In this context, mechanical thrombectomy has...

High Ischaemic Risk Criteria in Chronic Coronary Syndrome: Prevalence and Prognosis

Despite advances in the management of chronic coronary syndrome (CCS), including the widespread use of drug-eluting stents (DES) and the optimization of medical therapy,...

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

The expansion of transcatheter aortic valve implantation (TAVI) into younger and lower-risk populations has brought bioprosthetic valve thrombosis to the forefront as a clinically...